Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities - PubMed (original) (raw)
Comparative Study
. 2006 Mar 8;54(5):1611-20.
doi: 10.1021/jf0527403.
Affiliations
- PMID: 16506809
- DOI: 10.1021/jf0527403
Comparative Study
Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities
Mar Larrosa et al. J Agric Food Chem. 2006.
Abstract
Urolithins A and B (hydroxy-6H-dibenzo[b,d]pyran-6-one derivatives) are colonic microflora metabolites recently proposed as biomarkers of human exposure to dietary ellagic acid derivatives. Molecular models suggest that urolithins could display estrogenic and/or antiestrogenic activity. To this purpose, both urolithins and other known phytoestrogens (genistein, daidzein, resveratrol, and enterolactone) were assayed to evaluate the capacity to induce cell proliferation on the estrogen-sensitive human breast cancer MCF-7 cells as well as the ability to bind to alpha- and beta-estrogen receptors. Both urolithins A and B showed estrogenic activity in a dose-dependent manner even at high concentrations (40 microM), without antiproliferative or toxic effects, whereas the other phytoestrogens inhibited cell proliferation at high concentrations. Overall, urolithins showed weaker estrogenic activity than the other phytoestrogens. However, both urolithins displayed slightly higher antiestrogenic activity (antagonized the growth promotion effect of 17-beta-estradiol in a dose-dependent manner) than the other phytoestrogens. The IC(50) values for the ERalpha and ERbeta binding assays were 0.4 and 0.75 microM for urolithin A; 20 and 11 microM for urolithin B; 3 and 0.02 for genistein; and 2.3 and 1 for daidzein, respectively; no binding was detected for resveratrol and enterolactone. Urolithins A and B entered into MCF-7 cells and were metabolized to yield mainly urolithin-sulfate derivatives. These results, together with previous studies regarding absorption and metabolism of dietary ellagitannins and ellagic acid in humans, suggest that the gut microflora metabolites urolithins are potential endocrine-disrupting molecules, which could resemble other described "enterophytoestrogens" (microflora-derived metabolites with estrogenic/antiestrogenic activity). Further research is warranted to evaluate the possible role of ellagitannins and ellagic acid as dietary "pro-phytoestrogens".
Similar articles
- Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta.
Papoutsi Z, Kassi E, Tsiapara A, Fokialakis N, Chrousos GP, Moutsatsou P. Papoutsi Z, et al. J Agric Food Chem. 2005 Oct 5;53(20):7715-20. doi: 10.1021/jf0510539. J Agric Food Chem. 2005. PMID: 16190622 - Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
Kostelac D, Rechkemmer G, Briviba K. Kostelac D, et al. J Agric Food Chem. 2003 Dec 17;51(26):7632-5. doi: 10.1021/jf034427b. J Agric Food Chem. 2003. PMID: 14664520 - Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
Murata M, Midorikawa K, Koh M, Umezawa K, Kawanishi S. Murata M, et al. Biochemistry. 2004 Mar 9;43(9):2569-77. doi: 10.1021/bi035613d. Biochemistry. 2004. PMID: 14992594 - [Phytoestrogens].
Kinjo J. Kinjo J. Nihon Rinsho. 2000 Dec;58(12):2434-8. Nihon Rinsho. 2000. PMID: 11187733 Review. Japanese. - Phytoestrogens and breast cancer: a complex story.
Helferich WG, Andrade JE, Hoagland MS. Helferich WG, et al. Inflammopharmacology. 2008 Oct;16(5):219-26. doi: 10.1007/s10787-008-8020-0. Inflammopharmacology. 2008. PMID: 18815740 Review.
Cited by
- Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances.
Kumar AR, Nair B, Kamath AJ, Nath LR, Calina D, Sharifi-Rad J. Kumar AR, et al. Eur J Med Res. 2024 Oct 5;29(1):485. doi: 10.1186/s40001-024-02072-3. Eur J Med Res. 2024. PMID: 39367507 Free PMC article. Review. - An Updated Comprehensive Review of Plants and Herbal Compounds with Antiasthmatic Effect.
Rajizadeh MA, Najafipour H, Bejeshk MA. Rajizadeh MA, et al. Evid Based Complement Alternat Med. 2024 Feb 8;2024:5373117. doi: 10.1155/2024/5373117. eCollection 2024. Evid Based Complement Alternat Med. 2024. PMID: 39263346 Free PMC article. Review. - [Urolithin A alleviates respiratory syncytial virus-induced lung infection in neonatal mice by activating miR-136-mediated Sirt1 signaling].
Wang H, Xie H, Xu W, Li M. Wang H, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1370-1381. doi: 10.12122/j.issn.1673-4254.2024.07.17. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 39051083 Free PMC article. Chinese. - Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
Senavirathna T, Shafaei A, Lareu R, Balmer L. Senavirathna T, et al. Antioxidants (Basel). 2024 Apr 18;13(4):485. doi: 10.3390/antiox13040485. Antioxidants (Basel). 2024. PMID: 38671932 Free PMC article. Review. - The urolithin B nanomicellar delivery system as an efficient selective anticancer compound.
Albuthyab NOM, Hosseini H, Homayouni Tabrizi M, Kharaghani M, Saghravanian SS. Albuthyab NOM, et al. Mol Biol Rep. 2024 Jan 6;51(1):85. doi: 10.1007/s11033-023-09112-x. Mol Biol Rep. 2024. PMID: 38183506
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources